By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
2-Minute Step Test (2MST)
Summary
What it measures:
The 2-Minute Step Test (2MST) is used to assess aerobic endurance and functional fitness originally in the geriatric population (aged 60-94 years)1; however, this test is also used with populations such as cancer, Alzheimer dementia, cardiovascular disease (heart failure, HTN), stroke, renal disease, pulmonary disorder, healthy adults, and mixed populations (fallers, fragility, sarcopenia, and cognitive impairment).
Clinical Insights
The 2-minute Step Test outcome measure is a quick and simple tool to evaluate functional aerobic endurance when time and space are limited.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: November 1, 2021
Contact: practice@apta.org
Content Type: Test & Measure
Riley Caughlin, SPT, MS; Bayler Andrews, SPT, BS; Mike Richardson, PT, DPT, DHSc, Board-Certified Geriatric Clinical Specialist; Leslie Ayres, PT, DPT, Board-Certified Cardiovascular and Pulmonary Clinical Specialist; Kenneth Miller, PT, DPT, Board-Certified Geriatric Clinical Specialist
Paras Goel, PT, DPT, MEd, Board-Certified Geriatric Clinical Specialist
You Might Also Like...
CPG
Telerehabilitation in Physical Therapist Practice: A Clinical Practice Guideline From the American Physical Therapy AssociationMar 21, 2024
The guideline provides 7 recommendations that address the impact of, preparation for, and implementation of telerehabilitation in physical therapist practice.
CPG
Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesAug 29, 2023
This updated guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease.
CPG
ESC/ERS 2022 Guidelines for the Diagnosis and Treatment of Pulmonary HypertensionOct 7, 2022
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory